Rethinking the one-size-fits-most approach to venous thromboembolism prophylaxis after radical cystectomy.

CONCLUSIONS: Higher body mass index was associated with subprophylactic enoxaparin dosing after RC. Nearly two-thirds of patients had below target anti-factor Xa levels. This suggests that dosing could be further individualized, but given the low incidence of VTE, implications of dose-adjusted prophylaxis on VTE prevention remain unknown.
PMID: 32624425 [PubMed - as supplied by publisher]

Source: Urologic Oncology - July 1, 2020 Category: Urology & Nephrology Authors: Corona LE, Singhal U, Hafez K, Herrel LA, Kaffenberger SD, Montgomery JS, Morgan TM, Weizer AZ, Qin Y, Ambani SN Tags: Urol Oncol Source Type: research